Piper Sandler Reiterates Neutral on Dentsply Sirona, Lowers Price Target to $32
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Jason Bednar has reiterated a Neutral rating on Dentsply Sirona (NASDAQ:XRAY) and lowered the price target from $35 to $32.

May 03, 2024 | 1:20 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler has maintained a Neutral rating on Dentsply Sirona but reduced the price target from $35 to $32.
The reduction in the price target by Piper Sandler could lead to a negative short-term sentiment among investors, potentially causing a decrease in the stock price. The Neutral rating suggests no significant positive catalysts in the near term to counterbalance the lowered price target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100